Literature DB >> 27007829

Kinetics of Monoclonal Antibody Aggregation from Dilute toward Concentrated Conditions.

Lucrèce Nicoud1, Jakub Jagielski1, David Pfister1, Stefano Lazzari2, Jan Massant3, Marco Lattuada4, Massimo Morbidelli1.   

Abstract

Gaining understanding on the aggregation behavior of proteins under concentrated conditions is of both fundamental and industrial relevance. Here, we study the aggregation kinetics of a model monoclonal antibody (mAb) under thermal stress over a wide range of protein concentrations in various buffer solutions. We follow experimentally the monomer depletion and the aggregate growth by size exclusion chromatography with inline light scattering. We describe the experimental results in the frame of a kinetic model based on population balance equations, which allows one to discriminate the contributions of the conformational and of the colloidal stabilities to the global aggregation rate. Finally, we propose an expression for the aggregation rate constant, which accounts for solution viscosity, protein-protein interactions, as well as aggregate compactness. All these effects can be quantified by light scattering techniques. It is found that the model describes well the experimental data under dilute conditions. Under concentrated conditions, good model predictions are obtained when the solution pH is far below the isoelectric point (pI) of the mAb. However, peculiar effects arise when the solution pH is increased toward the mAb pI, and possible explanations are discussed.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27007829     DOI: 10.1021/acs.jpcb.5b11791

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   2.991


  11 in total

1.  Protein aggregation and mitigation strategy in low pH viral inactivation for monoclonal antibody purification.

Authors:  Weixin Jin; Zizhuo Xing; Yuanli Song; Chao Huang; Xuankuo Xu; Sanchayita Ghose; Zheng Jian Li
Journal:  MAbs       Date:  2019-09-02       Impact factor: 5.857

2.  ANTISOMA: A Computational Pipeline for the Reduction of the Aggregation Propensity of Monoclonal Antibodies.

Authors:  Katerina C Nastou; Eleftheria G Karataraki; Nikos C Papandreou; Anna-Isavella G Rerra; Vassiliki P Grimanelli; Ilias Maglogiannis; Stavros J Hamodrakas; Vassiliki A Iconomidou
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

3.  Improving Viscosity and Stability of a Highly Concentrated Monoclonal Antibody Solution with Concentrated Proline.

Authors:  Jessica J Hung; Barton J Dear; Aileen K Dinin; Ameya U Borwankar; Sumarth K Mehta; Thomas T Truskett; Keith P Johnston
Journal:  Pharm Res       Date:  2018-04-30       Impact factor: 4.200

4.  Formation of multimeric antibodies for self-delivery of active monomers.

Authors:  Yaron Dekel; Yossy Machluf; Tal Gefen; Gennady Eidelshtein; Alexander Kotlyar; Yaron Bram; Ehud Shahar; Farah Reslane; Elina Aizenshtein; Jacob Pitcovski
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

Review 5.  Viscosity Control of Protein Solution by Small Solutes: A Review.

Authors:  Taehun Hong; Kazuki Iwashita; Kentaro Shiraki
Journal:  Curr Protein Pept Sci       Date:  2018       Impact factor: 3.272

6.  Mechanistic reconstruction of glycoprotein secretion through monitoring of intracellular N-glycan processing.

Authors:  Ilaria Arigoni-Affolter; Ernesto Scibona; Chia-Wei Lin; David Brühlmann; Jonathan Souquet; Hervé Broly; Markus Aebi
Journal:  Sci Adv       Date:  2019-11-27       Impact factor: 14.136

7.  Single-Dimer Formation Rate Reveals Heterogeneous Particle Surface Reactivity.

Authors:  M R W Scheepers; L J van IJzendoorn; M W J Prins
Journal:  Langmuir       Date:  2019-10-28       Impact factor: 3.882

8.  Long-term stability predictions of therapeutic monoclonal antibodies in solution using Arrhenius-based kinetics.

Authors:  Drago Kuzman; Marko Bunc; Miha Ravnik; Fritz Reiter; Lan Žagar; Matjaž Bončina
Journal:  Sci Rep       Date:  2021-10-15       Impact factor: 4.379

Review 9.  Computational models for studying physical instabilities in high concentration biotherapeutic formulations.

Authors:  Marco A Blanco
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 5.857

10.  Evaluation of Crystal Zenith Microtiter Plates for High-Throughput Formulation Screening.

Authors:  J Alaina Floyd; Jeremy M Shaver; Alison J Gillespie; Unjy Park; Richard S Rogers; Nancy S Nightlinger; Yuko Ogata; Jeffrey J James; Bruce A Kerwin
Journal:  J Pharm Sci       Date:  2019-10-25       Impact factor: 3.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.